Thus, the induction of lipid peroxidation and ferroptosis by regulating the NRF2 pathway is a promising strategy for enhancing the anticancer effects of chemotherapy and radiotherapy, especially in therapy-resistant HCC cells. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.